Literature DB >> 23204821

Role of the immune system in hypertension: modulation by dietary antioxidants.

Sudesh Vasdev1, Jennifer Stuckless, Vernon Richardson.   

Abstract

Hypertension is a major health problem worldwide. Individuals with hypertension are at an increased risk for stroke, heart disease, and kidney failure. Although the etiology of essential hypertension has a genetic component, lifestyle factors such as diet play an important role. Insulin resistance is a common feature of hypertension in both humans and animal models affecting glucose and lipid metabolism producing excess aldehydes including methylglyoxal. These aldehydes react with proteins to form conjugates called advanced glycation end products (AGEs). This alters protein structure and function and can affect vascular and immune cells leading to their activation and secretion of inflammatory cytokines. AGEs also act via receptors for advanced glycation end products on these cells altering the function of antioxidant and metabolic enzymes, and ion channels. This results in an increase in cytosolic free calcium, decrease in nitric oxide, endothelial dysfunction, oxidative stress, peripheral vascular resistance, and infiltration of vascular and kidney tissue with inflammatory cells leading to hypertension. Supplementation with dietary antioxidants including vitamins C, E, or B(6), thiols such as cysteine and lipoic acid, have been shown to lower blood pressure and plasma inflammatory cytokines in animal models and humans with essential hypertension. A well-balanced diet rich in antioxidants that includes vegetables, fruits, low fat dairy products, low salt, and includes whole grains, poultry, fish and nuts, lowers blood pressure and vascular inflammation. These antioxidants may achieve their antihypertensive and anti-inflammatory/immunomodulatory effects by reducing AGEs and improving insulin resistance and associated alterations. Dietary supplementation with antioxidants may be a beneficial, inexpensive, front-line alterative treatment modality for hypertension.

Entities:  

Keywords:  Hypertension; T cells; advanced glycation end products; dietary antioxidants; immune system; inflammatory cytokines; insulin resistance; macrophages; oxidative stress; receptors for advanced glycation end products; renal damage; renin-angiotensin system

Year:  2011        PMID: 23204821      PMCID: PMC3331645          DOI: 10.1055/s-0031-1288941

Source DB:  PubMed          Journal:  Int J Angiol        ISSN: 1061-1711


  241 in total

1.  Peroxynitrite modification of protein thiols: oxidation, nitrosylation, and S-glutathiolation of functionally important cysteine residue(s) in the sarcoplasmic reticulum Ca-ATPase.

Authors:  R I Viner; T D Williams; C Schöneich
Journal:  Biochemistry       Date:  1999-09-21       Impact factor: 3.162

2.  Angiotensin II-induced insulin resistance is associated with enhanced insulin signaling.

Authors:  Takehide Ogihara; Tomoichiro Asano; Katsuyuki Ando; Yuko Chiba; Hideyuki Sakoda; Motonobu Anai; Nobuhiro Shojima; Hiraku Ono; Yukiko Onishi; Midori Fujishiro; Hideki Katagiri; Yasushi Fukushima; Masatoshi Kikuchi; Noriko Noguchi; Hiroyuki Aburatani; Issei Komuro; Toshiro Fujita
Journal:  Hypertension       Date:  2002-12       Impact factor: 10.190

3.  Effects of angiotensin II receptor blockade with valsartan on pro-inflammatory cytokines in patients with essential hypertension.

Authors:  Seiko Manabe; Takafumi Okura; Sanae Watanabe; Tomikazu Fukuoka; Jitsuo Higaki
Journal:  J Cardiovasc Pharmacol       Date:  2005-12       Impact factor: 3.105

4.  Lipoic acid prevents hypertension, hyperglycemia, and the increase in heart mitochondrial superoxide production.

Authors:  Adil E L Midaoui; Aziz Elimadi; Lingyun Wu; Pierre S Haddad; Jacques de Champlain
Journal:  Am J Hypertens       Date:  2003-03       Impact factor: 2.689

5.  Long-chain acyl-CoA esters as indicators of lipid metabolism and insulin sensitivity in rat and human muscle.

Authors:  B A Ellis; A Poynten; A J Lowy; S M Furler; D J Chisholm; E W Kraegen; G J Cooney
Journal:  Am J Physiol Endocrinol Metab       Date:  2000-09       Impact factor: 4.310

Review 6.  Nitric oxide, angiotensin II, and reactive oxygen species in hypertension and atherogenesis.

Authors:  Ivonne H Schulman; Ming-Sheng Zhou; Leopoldo Raij
Journal:  Curr Hypertens Rep       Date:  2005-02       Impact factor: 5.369

Review 7.  Angiotensin II and vascular inflammation.

Authors:  Zhong Jian Cheng; Heikki Vapaatalo; Eero Mervaala
Journal:  Med Sci Monit       Date:  2005-05-25

8.  Tocotrienol-rich fraction of palm oil exhibits anti-inflammatory property by suppressing the expression of inflammatory mediators in human monocytic cells.

Authors:  Shu-Jing Wu; Po-Len Liu; Lean-Teik Ng
Journal:  Mol Nutr Food Res       Date:  2008-08       Impact factor: 5.914

Review 9.  Inflammatory pathways and insulin action.

Authors:  G S Hotamisligil
Journal:  Int J Obes Relat Metab Disord       Date:  2003-12

10.  Vascular Angiotensin type 1 receptor expression is associated with vascular dysfunction, oxidative stress and inflammation in fructose-fed rats.

Authors:  Michael D Nyby; Karolin Abedi; Victoria Smutko; Pirooz Eslami; Michael L Tuck
Journal:  Hypertens Res       Date:  2007-05       Impact factor: 3.872

View more
  8 in total

Review 1.  Interrelationship Between Periapical Lesion and Systemic Metabolic Disorders.

Authors:  Hajime Sasaki; Kimito Hirai; Christine M Martins; Hisako Furusho; Ricardo Battaglino; Koshi Hashimoto
Journal:  Curr Pharm Des       Date:  2016       Impact factor: 3.116

Review 2.  The protective effect of lipoic acid on selected cardiovascular diseases caused by age-related oxidative stress.

Authors:  Beata Skibska; Anna Goraca
Journal:  Oxid Med Cell Longev       Date:  2015-04-08       Impact factor: 6.543

3.  Red cell distribution width and inappropriateness of left ventricular mass in patients with untreated essential hypertension.

Authors:  Lizhang Chen; Zhanzhan Li; Yanyan Li; Jing Xue; Peng Chen; Shipeng Yan; Caixiao Jiang; Yingyun Hu; Xing Qiao
Journal:  PLoS One       Date:  2015-03-20       Impact factor: 3.240

4.  Predictors of COVID-19 severity: a systematic review and meta-analysis.

Authors:  Mudatsir Mudatsir; Jonny Karunia Fajar; Laksmi Wulandari; Gatot Soegiarto; Muhammad Ilmawan; Yeni Purnamasari; Bagus Aulia Mahdi; Galih Dwi Jayanto; Suhendra Suhendra; Yennie Ayu Setianingsih; Romi Hamdani; Daniel Alexander Suseno; Kartika Agustina; Hamdan Yuwafi Naim; Muchamad Muchlas; Hamid Hunaif Dhofi Alluza; Nikma Alfi Rosida; Mayasari Mayasari; Mustofa Mustofa; Adam Hartono; Richi Aditya; Firman Prastiwi; Fransiskus Xaverius Meku; Monika Sitio; Abdullah Azmy; Anita Surya Santoso; Radhitio Adi Nugroho; Camoya Gersom; Ali A Rabaan; Sri Masyeni; Firzan Nainu; Abram L Wagner; Kuldeep Dhama; Harapan Harapan
Journal:  F1000Res       Date:  2020-09-09

5.  Cardiovascular health and risk of hospitalization with COVID-19: A Mendelian Randomization study.

Authors:  Marina Cecelja; Cathryn M Lewis; Ajay M Shah; Phil Chowienczyk
Journal:  JRSM Cardiovasc Dis       Date:  2021-11-19

6.  Mamao Pomace Extract Alleviates Hypertension and Oxidative Stress in Nitric Oxide Deficient Rats.

Authors:  Upa Kukongviriyapan; Veerapol Kukongviriyapan; Patchareewan Pannangpetch; Wanida Donpunha; Jintana Sripui; Amporn Sae-Eaw; Orachorn Boonla
Journal:  Nutrients       Date:  2015-07-28       Impact factor: 5.717

7.  Association of Animal and Plant Proteins Intake with Hypertension in Iranian Adult Population: Isfahan Healthy Heart Program.

Authors:  Sanaz Mehrabani; Mehdi Asemi; Jamshid Najafian; Firouzeh Sajjadi; Maryam Maghroun; Noushin Mohammadifard
Journal:  Adv Biomed Res       Date:  2017-08-31

Review 8.  Salt-dependent hypertension and inflammation: targeting the gut-brain axis and the immune system with Brazilian green propolis.

Authors:  Marcos Adriano Carlos Batista; Daiane Cristina de Assis Braga; Sandra Aparecida Lima de Moura; Gustavo Henrique Bianco de Souza; Orlando David Henrique Dos Santos; Leonardo Máximo Cardoso
Journal:  Inflammopharmacology       Date:  2020-08-12       Impact factor: 4.473

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.